DREAM anticorps (Middle Region)
Aperçu rapide pour DREAM anticorps (Middle Region) (ABIN927398)
Antigène
Voir toutes DREAM (KCNIP3) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Réactivité croisée
- Souris
-
Purification
- Purified
-
Immunogène
- Kcnip3 antibody was raised in rabbit using the middle region of Kcnip3 as the immunogen
-
-
-
-
Indications d'application
- Optimal conditions should be determined by the investigator.
-
Commentaires
-
Kcnip3 Blocking Peptide, (ABIN5614280), is also available for use as a blocking control in assays to test for specificity of this Kcnip3 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- DREAM (KCNIP3) (Kv Channel Interacting Protein 3, Calsenilin (KCNIP3))
-
Autre désignation
- Kcnip3
-
Sujet
- Cdx1 could play a role in the terminal differentiation of the intestine. Synonyms: Polyclonal Kcnip3 antibody, Anti-Kcnip3 antibody, Kv channel interacting protein 3, calsenilin antibody, 4933407H12Rik antibody, AI413860 antibody, Csen antibody, DREAM antibody, KChIP3 antibody, R74849 antibody.
Antigène
-